1. | kingsnymptonps | |
2. | ghueck | |
3. | ccaseyrn7 | |
4. | jadeone11 | |
5. | benjimichigan |
1. | kingsnymptonps | |
2. | ghueck | |
3. | ccaseyrn7 | |
4. | jadeone11 | |
5. | benjimichigan |
1. | ccaseyrn7 01/25/2018 They get cash to work on their other targets |
2. | kingsnymptonps 01/25/2018 Heading North. |
3. | ghueck 03/15/2018 Misses EPS loss estimates by $0.15. Beats on revenues. |
4. | ccaseyrn7 01/25/2018 ah huh. |
5. | jadeone11 01/26/2018 Any problems here? |
6. | gojeck 01/25/2018 Awesome news! |
7. | jadeone11 08/07/2018 Beats EPS loss estimates by $0.21 and beats on revenues |
8. | kingsnymptonps 01/25/2018 $KPTI NEWS! Big money! |
9. | ghueck 01/26/2018 Been 2 good days now an offering |
10. | benjimichigan 05/24/2018 Karyopharm and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor and KPT-9274 in China and Other Regions in Asia |